Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
36.12
-0.44 (-1.20%)
Sep 3, 2025, 10:59 AM - Market open

Company Description

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms.

The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment.

It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.

The company was founded in 2008 and is headquartered in Irving, Texas.

Caris Life Sciences, Inc.
Caris Life Sciences logo
CountryUnited States
Founded2008
IPO DateJun 18, 2025
IndustryBiotechnology
SectorHealthcare
Employees1,769
CEODavid Halbert

Contact Details

Address:
750 West John Carpenter Freeway, Suite 800
Irving, Texas 75039
United States
Phone866 771 8946
Websitecarislifesciences.com

Stock Details

Ticker SymbolCAI
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$21.00
CIK Code0002019410
ISIN NumberUS1421521071
Employer ID85-2077369
SIC Code8071

Key Executives

NamePosition
Dr. David Dean Halbert M.D.Chairman, Chief Executive Officer and Founder
Brian J. Brille J.D.Executive Vice Chairman and Executive Vice President
Dr. David Spetzler M.B.A., M.S., MBA, MS, Ph.D.President
Luke PowerSenior Vice President, Chief Financial Officer and Chief Accounting Officer
Jon Mark HarmonSenior Vice President and Chief Operations Officer
Dr. Valeriy DomenyukSenior Vice President and Chief Technology Officer
Dr. Milan Radovich Ph.D.Senior Vice President and Chief Scientific Officer
Ginger Appleberry J.D.Senior Vice President, Deputy General Counsel and Chief Compliance Officer
J. Russel DentonSenior Vice President, General Counsel and Secretary
Narendra ChokshiSenior Vice President of Corporate Development

Latest SEC Filings

DateTypeTitle
Aug 14, 2025SCHEDULE 13GFiling
Aug 13, 2025SCHEDULE 13GFiling
Aug 12, 202510-QQuarterly Report
Aug 12, 20258-KCurrent Report
Jul 28, 2025SCHEDULE 13GFiling
Jun 24, 2025SCHEDULE 13GFiling
Jun 20, 20258-KCurrent Report
Jun 20, 2025424B4Prospectus
Jun 18, 2025S-8Securities to be offered to employees in employee benefit plans
Jun 17, 2025EFFECTNotice of Effectiveness